Arteris, Inc. Appoints New CFO Saurabh Sinha

What Happened
Arteris, Inc. announced on August 3, 2026 (filed via Form 8‑K) that the Board appointed Saurabh Sinha as Chief Financial Officer, principal financial officer and principal accounting officer, effective September 8, 2026. The company and Mr. Sinha entered an offer letter dated July 16, 2026. Mr. Sinha most recently served as CFO of Aeva Technologies (since September 2020) and previously held finance roles at JUUL Labs and InvenSense.

Key Details

• Base salary: $440,000 per year.
• Annual cash bonus: eligible under the Management Performance Bonus Plan with a target of 60% of base salary.
• Equity awards as inducement (intended grant effective on Start Date):
  • 2026 PSU: target value $1,000,000. Vesting requires (1) company achieving trailing four-quarter revenue of $200,000,000 or greater on or before Dec 31, 2030, and then (2) company stock achieving a 15-day average closing price of $65 or greater on or before Dec 31, 2031, subject to continued service.
  • RSU: target value $3,700,000, vesting over four years (25% at first anniversary, remainder vesting pro rata by day tied to quarterly vesting schedule commencing Jan 1, 2028).
  • 2027 PSU: target value $1,000,000, to vest based on LTIP performance metrics for the period beginning Jan 1, 2027.
• Number of shares for each award to be determined by dividing target grant value by the 30‑day trailing average share price before grant.
• Mr. Sinha is eligible for the company’s executive change‑in‑control severance and indemnification agreements. No family relationships or related‑party transactions disclosed.

Why It Matters
The appointment establishes new leadership for Arteris’s finance and accounting functions at a critical time. Compensation mixes cash and sizeable equity tied to revenue and stock‑price performance, aligning the CFO’s incentives with company growth targets but also creating potential future equity dilution and compensation expense if awards vest. Investors should note the aggressive long‑term revenue and share‑price hurdles attached to the PSUs (revenues of $200M trailing four quarters and a $65 share‑price threshold), the timing of the grants (effective Sept 8, 2026) and the material size of the equity packages relative to company pay practices.